scorecard

You Searched For "Merck" and got 20 results


Sort By:


Business Insider Latest Story Image
1 min read

Retail investors are dumping shares of COVID-19 vaccine makers and piling into antiviral pill maker Merck, data shows

Merck shares have jumped since the drug maker said molnupiravir cuts the risk of COVID hospitalizat…

Carla Mozée   


Business Insider Latest Story Image
2 mins read

Pharma giant Merck just jumped into the coronavirus race with 2 vaccine candidates slated to start human testing this year

Announcing 3 deals on Tuesday, Merck unveiled its top research efforts for a coronavirus vaccine as…

Andrew Dunn   


Business Insider Latest Story Image
4 mins read

Merck is set to make billions off a COVID-19 pill that could change the pandemic. Here's why some countries will pay more than others.

Merck's antiviral has not yet been authorized, but the company already has plans to distribute the …

Andrew Dunn   


Business Insider Latest Story Image
2 mins read

US drug giant Merck drops out the COVID-19 vaccine race, after its 2 vaccine candidates failed to generate a strong immune response

Merck said the vaccines failed to produce an adequate immune response. It would focus on two new CO…

Dr. Catherine Schuster-Bruce   


Business Insider Latest Story Image
1 min read

Merck sells its investment stake in Moderna after recording a 'substantial' gain

Merck initially invested $50 million in Moderna before it was public in 2015, and subsequently inve…

Matthew Fox   


Business Insider Latest Story Image
1 min read

Merck CEO Kenneth Frazier is retiring. He is one of only 4 Black CEOs in the Fortune 500, and famously stood up to Trump over Charlottesville in 2017.

Kenneth Frazier, who has led the US pharma giant Merck for nearly 30 years, is retiring, and will b…

Kate Duffy,Reuters   


Business Insider Latest Story Image
2 mins read

Merck jumps 10% as the drugmaker says its antiviral pill cuts the risk of hospitalizations and deaths in COVID patients

Merck already has a deal to supply 1.7 million courses of antiviral pill molnupiravir to the US gov…

Carla Mozée   


Business Insider Latest Story Image
3 mins read

Merck's CHRO on how to 'innovate, upgrade, and use technology' to broaden talent and boost employee morale

Steven Mizell, Merck's EVP and CHRO, shares how the company advanced its human resources function a…

Sharon Goldman   


Business Insider Latest Story Image
1 min read

Pandion Therapeutics soars 132% after Merck agrees to buy the biotech for $1.85 billion

Pandion is a clinical-stage biotechnology company that is developing therapeutics for patients livi…

Matthew Fox   


Business Insider Latest Story Image
2 mins read

Merck will reportedly help produce Johnson & Johnson COVID-19 vaccine shots after failing to make its own

The Washington Post reported that President Joe Biden would announce the partnership between the tw…

Allana Akhtar   


Business Insider Latest Story Image
1 min read

A new pill designed to treat active COVID-19 infections was just approved by the UK, the first country to do so

Early trial results found that Merck's molnupiravir, the first antiviral designed to treat COVID-19…

Mary Hanbury   


Business Insider Latest Story Image
3 mins read

The FDA could authorize the first COVID-19 pill in December - here's who may be eligible

Next month, the FDA will meet to discuss Merck's antiviral pill for adults with mild to moderate CO…

Aria Bendix   


Business Insider Latest Story Image
2 mins read

AbbVie, Merck, and Pfizer shares jump after Warren Buffett's Berkshire Hathaway reveals it bought them last quarter

The "Buffett Effect" kicked in after the famed investor disclosed about $6 billion in new pharmaceu…

Theron Mohamed   


Business Insider Latest Story Image
1 min read

Grace Dean   


Business Insider Latest Story Image
3 mins read

Merck Is Taking A Huge Risk By Betting On An Alzheimer's Treatment

It's not for lack of trying. Companies have sunk billions and billions into the search for a treatm…

Max Nisen   


Business Insider Latest Story Image
4 mins read

One crucial quote from Merck CEO Ken Frazier at an event for big-time investors in Manhattan shows the US drug giant at a crossroads

After nearly a decade of leadership by Frazier, Merck is preparing for transition at the top, thoug…

Emma Court   


Business Insider Latest Story Image
1 min read

US stocks climb as progress on Merck's antiviral pill offsets new inflation data

Merck's positive drug data helped turn around US futures this morning even as core inflation saw it…

Matthew Fox   


Business Insider Latest Story Image
3 mins read

Pharma giant Merck just lowered the prices of some of its medications

"Merck (NYSE:MRK), known as MSD outside the United States and Canada, has a long history of respons…

Lydia Ramsey   


Business Insider Latest Story Image
2 mins read

Trump just put Merck's CEO on blast over drug prices - here's what the company's track record actually looks like

Merck, which known for its cancer immunotherapy drug Keytruda and its vaccines business, has not be…

Lydia Ramsey   


Business Insider Latest Story Image
2 mins read

German firm Merck KGaA eyeing Indian market for its pharma, consumer health business

However, Garijo warned of immediate challenges, like concerns over pricing of medicines and recogni…